InsidersTradesSigma
Follow the Evogene Ltd. stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €8.7m. The latest transaction was disclosed on 13 August 2026 (Acquisition). Among the most active insiders: RECANATI LEON. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Evogene Ltd. is a biotechnology company that utilizes advanced technologies to enhance crops and agricultural products. It focuses on developing innovative solutions for sustainable agriculture.